Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone

Vivian Fonseca; Cyrus Desouza; Amna N. Khan

doi:10.1136/ebm1098

Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone

Vivian Fonseca, Cyrus Desouza, Amna N. Khan

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	115-116
Number of pages	2
Journal	Evidence-Based Medicine
Volume	15
Issue number	4
DOIs	https://doi.org/10.1136/ebm1098
State	Published - Aug 2010

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1136/ebm1098

Cite this

@article{e3849e3916b74bc68eaceb7ca6e46ebd,

title = "Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone",

author = "Vivian Fonseca and Cyrus Desouza and Khan, {Amna N.}",

year = "2010",

month = aug,

doi = "10.1136/ebm1098",

language = "English (US)",

volume = "15",

pages = "115--116",

journal = "Evidence-Based Medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "4",

}

TY - JOUR

T1 - Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone

AU - Fonseca, Vivian

AU - Desouza, Cyrus

AU - Khan, Amna N.

PY - 2010/8

Y1 - 2010/8

UR - http://www.scopus.com/inward/record.url?scp=77955252981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955252981&partnerID=8YFLogxK

U2 - 10.1136/ebm1098

DO - 10.1136/ebm1098

M3 - Comment/debate

C2 - 20610447

AN - SCOPUS:77955252981

VL - 15

SP - 115

EP - 116

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

SN - 1356-5524

IS - 4

ER -

Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this